ID   PAK4_HUMAN              Reviewed;         591 AA.
AC   O96013; B4DGG6; Q8N4E1; Q8NCH5; Q8NDE3; Q9BU33; Q9ULS8;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   05-OCT-2010, entry version 114.
DE   RecName: Full=Serine/threonine-protein kinase PAK 4;
DE            EC=2.7.11.1;
DE   AltName: Full=p21-activated kinase 4;
DE            Short=PAK-4;
GN   Name=PAK4; Synonyms=KIAA1142;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Lymphoma;
RX   MEDLINE=99043860; PubMed=9822598; DOI=10.1093/emboj/17.22.6527;
RA   Abo A., Qu J., Cammarano M.S., Dan C., Fritsch A., Baud V.,
RA   Belisle B., Minden A.;
RT   "PAK4, a novel effector for Cdc42Hs, is implicated in the
RT   reorganization of the actin cytoskeleton and in the formation of
RT   filopodia.";
RL   EMBO J. 17:6527-6540(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Neuroblastoma;
RA   Melnick M.B.;
RL   Submitted (MAY-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   MEDLINE=20039618; PubMed=10574461; DOI=10.1093/dnares/6.5.329;
RA   Hirosawa M., Nagase T., Ishikawa K., Kikuno R., Nomura N., Ohara O.;
RT   "Characterization of cDNA clones selected by the GeneMark analysis
RT   from size-fractionated cDNA libraries from human brain.";
RL   DNA Res. 6:329-336(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 264-591 (ISOFORM 1).
RC   TISSUE=Brain, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 4).
RC   TISSUE=Eye, Pancreas, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION.
RX   PubMed=15660133; DOI=10.1038/sj.emboj.7600543;
RA   Soosairajah J., Maiti S., Wiggan O., Sarmiere P., Moussi N.,
RA   Sarcevic B., Sampath R., Bamburg J.R., Bernard O.;
RT   "Interplay between components of a novel LIM kinase-slingshot
RT   phosphatase complex regulates cofilin.";
RL   EMBO J. 24:473-486(2005).
RN   [9]
RP   INTERACTION WITH ARHGEF2.
RX   PubMed=15827085; DOI=10.1242/jcs.02313;
RA   Callow M.G., Zozulya S., Gishizky M.L., Jallal B., Smeal T.;
RT   "PAK4 mediates morphological changes through the regulation of GEF-
RT   H1.";
RL   J. Cell Sci. 118:1861-1872(2005).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-474, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99; SER-104; SER-148;
RP   SER-167; SER-181; THR-207; SER-267; SER-291 AND SER-474, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-41; SER-104; SER-148;
RP   SER-167; SER-181; THR-187; THR-207; SER-258; SER-267; THR-277; SER-291
RP   AND SER-474, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181 AND SER-474, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-41; SER-104; SER-142;
RP   SER-148; SER-167; SER-181; THR-187; SER-195; THR-207; SER-242;
RP   SER-258; SER-267; SER-291 AND SER-474, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181 AND SER-474, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 300-591, AND PHOSPHORYLATION
RP   AT SER-474.
RA   Eswaran J., Debreczeni J.E., Bunkoczi G., Filippakopoulos P., Das S.,
RA   Fedorov O., Sundstrom M., Arrowsmith C., Edwards A., von Delft F.,
RA   Knapp S.;
RT   "Crystal structure of the human p21-activated kinase 4.";
RL   Submitted (JUL-2005) to the PDB data bank.
RN   [18]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLN-135 AND THR-139.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Activates the JNK pathway. Plays a role in the
CC       reorganization of the actin cytoskeleton and in the formation of
CC       filopodia. Phosphorylates and inactivates the protein phosphatase
CC       SSH1, leading to increased inhibitory phosphorylation of the actin
CC       binding/depolymerizing factor cofilin. Decreased cofilin activity
CC       may lead to stabilization of actin filaments. Phosphorylates
CC       ARHGEF2.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Interacts with FGFR2 and GRB2 (By similarity). Interacts
CC       tightly with GTP-bound but not GDP-bound CDC42/p21 and weakly with
CC       RAC1. Interacts with its substrate ARHGEF2.
CC   -!- INTERACTION:
CC       P60953:CDC42; NbExp=1; IntAct=EBI-713738, EBI-81752;
CC       Q38SD2:LRRK1; NbExp=1; IntAct=EBI-713738, EBI-1050422;
CC       P61981:YWHAG; NbExp=1; IntAct=EBI-713738, EBI-359832;
CC       P27348:YWHAQ; NbExp=1; IntAct=EBI-713738, EBI-359854;
CC       P63104:YWHAZ; NbExp=1; IntAct=EBI-713738, EBI-347088;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=O96013-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O96013-2; Sequence=VSP_004892, VSP_004893;
CC         Note=No experimental confirmation available;
CC       Name=3;
CC         IsoId=O96013-3; Sequence=VSP_017572;
CC       Name=4;
CC         IsoId=O96013-4; Sequence=VSP_017573;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Highest expression in prostate, testis and
CC       colon.
CC   -!- PTM: Autophosphorylated on serine residues when activated by
CC       CDC42/p21.
CC   -!- PTM: Phosphorylated on tyrosine residues upon stimulation of FGFR2
CC       (By similarity).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily.
CC   -!- SIMILARITY: Contains 1 CRIB domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA86456.1; Type=Erroneous initiation;
CC       Sequence=BAC11166.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ011855; CAA09820.1; -; mRNA.
DR   EMBL; AF005046; AAD01210.1; -; mRNA.
DR   EMBL; AB032968; BAA86456.1; ALT_INIT; mRNA.
DR   EMBL; AK074728; BAC11166.1; ALT_INIT; mRNA.
DR   EMBL; AK294586; BAG57777.1; -; mRNA.
DR   EMBL; AL834236; CAD38914.2; -; mRNA.
DR   EMBL; CH471126; EAW56861.1; -; Genomic_DNA.
DR   EMBL; BC002921; AAH02921.1; -; mRNA.
DR   EMBL; BC011368; AAH11368.1; -; mRNA.
DR   EMBL; BC025282; AAH25282.1; -; mRNA.
DR   EMBL; BC034511; AAH34511.1; -; mRNA.
DR   IPI; IPI00014068; -.
DR   IPI; IPI00178714; -.
DR   IPI; IPI00384231; -.
DR   IPI; IPI00556065; -.
DR   RefSeq; NP_001014831.1; -.
DR   RefSeq; NP_001014832.1; -.
DR   RefSeq; NP_001014834.1; -.
DR   RefSeq; NP_001014835.1; -.
DR   RefSeq; NP_005875.1; -.
DR   UniGene; Hs.20447; -.
DR   PDB; 2BVA; X-ray; 2.30 A; A/B=300-591.
DR   PDB; 2CDZ; X-ray; 2.30 A; A=291-591.
DR   PDB; 2J0I; X-ray; 1.60 A; A=291-591.
DR   PDB; 2OV2; X-ray; 2.10 A; I/J/K/L/M/N/O/P=10-44.
DR   PDB; 2Q0N; X-ray; 1.75 A; A=291-591.
DR   PDB; 2X4Z; X-ray; 2.10 A; A=300-591.
DR   PDBsum; 2BVA; -.
DR   PDBsum; 2CDZ; -.
DR   PDBsum; 2J0I; -.
DR   PDBsum; 2OV2; -.
DR   PDBsum; 2Q0N; -.
DR   PDBsum; 2X4Z; -.
DR   ProteinModelPortal; O96013; -.
DR   IntAct; O96013; 14.
DR   MINT; MINT-1387795; -.
DR   STRING; O96013; -.
DR   PhosphoSite; O96013; -.
DR   PRIDE; O96013; -.
DR   Ensembl; ENST00000358301; ENSP00000351049; ENSG00000130669.
DR   Ensembl; ENST00000360442; ENSP00000353625; ENSG00000130669.
DR   Ensembl; ENST00000435673; ENSP00000392753; ENSG00000130669.
DR   GeneID; 10298; -.
DR   KEGG; hsa:10298; -.
DR   UCSC; uc002okj.1; human.
DR   UCSC; uc002okm.1; human.
DR   UCSC; uc002okp.1; human.
DR   CTD; 10298; -.
DR   GeneCards; GC19P039616; -.
DR   H-InvDB; HIX0015110; -.
DR   HGNC; HGNC:16059; PAK4.
DR   HPA; CAB025747; -.
DR   MIM; 605451; gene.
DR   PharmGKB; PA32920; -.
DR   eggNOG; prNOG17248; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG108518; -.
DR   InParanoid; O96013; -.
DR   OMA; VDPACIT; -.
DR   OrthoDB; EOG9VX4QH; -.
DR   PhylomeDB; O96013; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; fgf_pathway; FGF signaling pathway.
DR   Reactome; REACT_18266; Axon guidance.
DR   NextBio; 39028; -.
DR   ArrayExpress; O96013; -.
DR   Bgee; O96013; -.
DR   CleanEx; HS_PAK4; -.
DR   Genevestigator; O96013; -.
DR   GermOnline; ENSG00000130669; Homo sapiens.
DR   GO; GO:0005794; C:Golgi apparatus; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006928; P:cellular component movement; TAS:ProtInc.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000095; PAK_box_Rho-bd.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR015750; Ser/Thr_kinase_Pak-rel.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   PANTHER; PTHR22986:SF84; Pak_like; 1.
DR   Pfam; PF00786; PBD; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00285; PBD; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50108; CRIB; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; FALSE_NEG.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Kinase; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    591       Serine/threonine-protein kinase PAK 4.
FT                                /FTId=PRO_0000086474.
FT   DOMAIN       11     24       CRIB.
FT   DOMAIN      321    572       Protein kinase.
FT   NP_BIND     327    335       ATP (By similarity).
FT   REGION       25    320       Linker.
FT   REGION      298    323       GEF-interaction domain (GID).
FT   ACT_SITE    440    440       Proton acceptor (By similarity).
FT   BINDING     350    350       ATP (By similarity).
FT   MOD_RES      41     41       Phosphoserine.
FT   MOD_RES      99     99       Phosphoserine.
FT   MOD_RES     104    104       Phosphoserine.
FT   MOD_RES     142    142       Phosphoserine.
FT   MOD_RES     148    148       Phosphoserine.
FT   MOD_RES     167    167       Phosphoserine.
FT   MOD_RES     181    181       Phosphoserine.
FT   MOD_RES     187    187       Phosphothreonine.
FT   MOD_RES     195    195       Phosphoserine.
FT   MOD_RES     207    207       Phosphothreonine.
FT   MOD_RES     242    242       Phosphoserine.
FT   MOD_RES     258    258       Phosphoserine.
FT   MOD_RES     267    267       Phosphoserine.
FT   MOD_RES     277    277       Phosphothreonine.
FT   MOD_RES     291    291       Phosphoserine.
FT   MOD_RES     474    474       Phosphoserine; by autocatalysis.
FT   VAR_SEQ      69    221       Missing (in isoform 3).
FT                                /FTId=VSP_017572.
FT   VAR_SEQ     120    120       E -> K (in isoform 2).
FT                                /FTId=VSP_004892.
FT   VAR_SEQ     121    285       Missing (in isoform 2).
FT                                /FTId=VSP_004893.
FT   VAR_SEQ     132    221       Missing (in isoform 4).
FT                                /FTId=VSP_017573.
FT   VARIANT     135    135       R -> Q (in dbSNP:rs56099436).
FT                                /FTId=VAR_040970.
FT   VARIANT     139    139       A -> T (in dbSNP:rs35655056).
FT                                /FTId=VAR_040971.
FT   STRAND       15     26
FT   TURN         27     30
FT   STRAND       31     34
FT   HELIX        37     39
FT   TURN         40     42
FT   HELIX       306    309
FT   TURN        318    320
FT   HELIX       364    371
FT   STRAND      381    389
FT   STRAND      391    395
FT   HELIX       404    407
FT   HELIX       414    433
FT   HELIX       443    445
FT   STRAND      446    448
FT   STRAND      454    456
FT   HELIX       479    481
FT   HELIX       484    487
FT   HELIX       495    509
FT   TURN        514    517
FT   HELIX       520    528
FT   HELIX       543    552
FT   HELIX       557    559
FT   HELIX       563    566
FT   HELIX       570    574
FT   HELIX       578    585
SQ   SEQUENCE   591 AA;  64072 MW;  04C2A5C0B06427D5 CRC64;
     MFGKRKKRVE ISAPSNFEHR VHTGFDQHEQ KFTGLPRQWQ SLIEESARRP KPLVDPACIT
     SIQPGAPKTI VRGSKGAKDG ALTLLLDEFE NMSVTRSNSL RRDSPPPPAR ARQENGMPEE
     PATTARGGPG KAGSRGRFAG HSEAGGGSGD RRRAGPEKRP KSSREGSGGP QESSRDKRPL
     SGPDVGTPQP AGLASGAKLA AGRPFNTYPR ADTDHPSRGA QGEPHDVAPN GPSAGGLAIP
     QSSSSSSRPP TRARGAPSPG VLGPHASEPQ LAPPACTPAA PAVPGPPGPR SPQREPQRVS
     HEQFRAALQL VVDPGDPRSY LDNFIKIGEG STGIVCIATV RSSGKLVAVK KMDLRKQQRR
     ELLFNEVVIM RDYQHENVVE MYNSYLVGDE LWVVMEFLEG GALTDIVTHT RMNEEQIAAV
     CLAVLQALSV LHAQGVIHRD IKSDSILLTH DGRVKLSDFG FCAQVSKEVP RRKSLVGTPY
     WMAPELISRL PYGPEVDIWS LGIMVIEMVD GEPPYFNEPP LKAMKMIRDN LPPRLKNLHK
     VSPSLKGFLD RLLVRDPAQR ATAAELLKHP FLAKAGPPAS IVPLMRQNRT R
//
